Manufacturing and Process Scale-Up
Poly(lactide-co-glycolide) (PLGA) has been used widely for developing long-acting injectable formulations, including Ozurdex®, a miniature-size implant for ocular delivery of dexamethasone for 3 months. Previously, the sequential exposure of semi-solvents and subsequent morphological evaluations by SAVI were developed to elucidate the internal microstructural characteristics of PLGA microparticles [1]. The current work applied the SAVI method to study dexamethasone-loaded mini-rods.
John Garner, B.S. (he/him/his)
General Manager
Akina, Inc.
West Lafayette, Indiana, United States